全文获取类型
收费全文 | 11048篇 |
免费 | 677篇 |
国内免费 | 316篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 74篇 |
妇产科学 | 47篇 |
基础医学 | 1252篇 |
口腔科学 | 98篇 |
临床医学 | 697篇 |
内科学 | 1342篇 |
皮肤病学 | 111篇 |
神经病学 | 650篇 |
特种医学 | 259篇 |
外国民族医学 | 1篇 |
外科学 | 305篇 |
综合类 | 1208篇 |
一般理论 | 1篇 |
预防医学 | 481篇 |
眼科学 | 217篇 |
药学 | 4736篇 |
中国医学 | 283篇 |
肿瘤学 | 249篇 |
出版年
2023年 | 109篇 |
2022年 | 246篇 |
2021年 | 334篇 |
2020年 | 249篇 |
2019年 | 251篇 |
2018年 | 218篇 |
2017年 | 223篇 |
2016年 | 243篇 |
2015年 | 298篇 |
2014年 | 401篇 |
2013年 | 602篇 |
2012年 | 425篇 |
2011年 | 519篇 |
2010年 | 430篇 |
2009年 | 364篇 |
2008年 | 396篇 |
2007年 | 396篇 |
2006年 | 455篇 |
2005年 | 425篇 |
2004年 | 379篇 |
2003年 | 363篇 |
2002年 | 320篇 |
2001年 | 271篇 |
2000年 | 250篇 |
1999年 | 226篇 |
1998年 | 216篇 |
1997年 | 196篇 |
1996年 | 172篇 |
1995年 | 190篇 |
1994年 | 226篇 |
1993年 | 176篇 |
1992年 | 202篇 |
1991年 | 202篇 |
1990年 | 195篇 |
1989年 | 181篇 |
1988年 | 178篇 |
1987年 | 152篇 |
1986年 | 132篇 |
1985年 | 162篇 |
1984年 | 148篇 |
1983年 | 94篇 |
1982年 | 161篇 |
1981年 | 128篇 |
1980年 | 134篇 |
1979年 | 96篇 |
1978年 | 83篇 |
1977年 | 64篇 |
1976年 | 46篇 |
1975年 | 24篇 |
1974年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 828 毫秒
41.
为研究和比较化学致癌物对人呼吸道上皮细胞和纤维母细胞的损伤及损伤后DNA修复合成的差异,作者用直接致癌物4-硝基喹啉-1-氧化物(4-NQO)和间接致癌物3,4-苯并芘(BaP)处理人胚鼻咽、气管上皮细胞和纤维母细胞,用放射自显影术测定这3种细胞的非时序脱氧核糖核酸合成(UDS)。用4-NQO处理后,这3种细胞的UDS均呈明显的剂量依赖(dose dePendency)关系,但气管和鼻咽上皮细胞UDS平均分别是纤维母细胞的3.0和2.4倍。用BaP处理后,气管和鼻咽上皮细胞UDS呈现明显的剂量依赖关系,而纤维母细胞未见这种关系。气管和鼻咽上皮细胞的UDS平均分别是纤维母细胞的8.6和3.0倍。 相似文献
42.
43.
J. P. De La Cruz S. Cámara M. A. Frutos F. Sánchez De La Cuesta 《European journal of clinical pharmacology》1992,43(3):307-309
Summary The antiproteinuric effect of the antiplatelet agent dipyridamole has been assessed after inhibiton of thromboxane B2 (TxB2) synthesis in 8 patients with confirmed membranous glomerulonephritis.
There were three study periods, each of 30 days, and 45 days apart, namely a washout period, treatment with dipyridamole 300
mg/d, and dipyridamole 225 mg/d plus aspirin 150 mg/d. On Days 1 and 30 of each study period serum and urine creatinine, 24-h
excretion of protein, creatinine clearance, platelet aggregometry on whole blood and serum TxB2 were measured.
Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h
protein excretion; the latter amounted to 54% with dipyridamole alone and 56 % with dipyridamole plus aspirin (NS). Dipyridamole
plus aspirin caused an 82 % reduction in serum TxB2. 相似文献
44.
JIN-SONG HE SATOSHI HORIKOSHI KAZUHIKO FUNABIKI ISAO SHIRATO YASUHIKO TOMINO 《Nephrology (Carlton, Vic.)》2002,7(2):83-86
SUMMARY: Inhibition of mevalonate synthesis by several statins has been shown to suppress DNA synthesis in glomerular mesangial cells. In the present study, we investigated the effect of a new statin, cerivastatin, on fetal calf serum (FCS)-induced DNA synthesis of cultured rat mesangial cells. Cultured rat mesangial cells were stimulated by 10% FCS in the presence or absence of cerivastatin and mevalonate. 5-bromo-2-deoxyuridine (BrdU) incorporation was used to assess DNA synthesis. the present study showed that 10% FCS caused marked stimulation of DNA synthesis in the mesangial cells. Cerivastatin inhibited FCS-stimulated BrdU incorporation in a dose-dependent manner. IC50 was approximately 1 umol/L. Exogenous mevalonate, farnesyl pyrophosphate and geranylgeranyl pyrophosphate significantly prevented the inhibitory effect of cerivastatin on DNA replication. It appears that cerivastatin, by inhibiting the synthesis of mevalonate, may suppress DNA synthesis in the mesangial cells. 相似文献
45.
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. 总被引:2,自引:0,他引:2
Andreas Fusshoeller Marcus Plail Bernd Grabensee Joerg Plum 《Nephrology, dialysis, transplantation》2004,19(8):2101-2106
BACKGROUND: In chronic ambulatory peritoneal dialysis, bicarbonate-buffered fluids, with their neutral pH and less advanced glycosylation end-products (AGE) and glucose degradation products (GDP), have better biocompatibility than conventional peritoneal dialysis (PD) solutions. That difference may be more beneficial in automated peritoneal dialysis (APD), due to its more frequent exchanges and longer contact times with fresh dialysate. We performed a prospective, randomized study in APD patients to compare the biocompatibility of conventional and bicarbonate/lactate-buffered PD fluids. METHODS: We randomized 14 APD patients to have APD with either conventional or bicarbonate/lactate-based fluids. After 6 months, both groups changed to the other solution. The overall observation period was 12 months. After 1 and 5 months and again after 7 and 11 months, phagocytotic and respiratory burst capacities of effluent peritoneal macrophages were determined. Plasma interleukin (IL)-6 and C-reactive protein (CRP) as well as effluent IL-6, CRP, transforming growth factor (TGF)-beta 1, AGE and CA125 concentrations were measured. Inflow pain was quantified using a patient questionnaire. RESULTS: Respiratory burst capacity remained unchanged and phagocytotic activity increased significantly during APD (P<0.001) with the bicarbonate/lactate fluid. Effluent IL-6 release was significantly lower than with the lactate fluid (P<0.05). While in the effluent TGF-beta 1 was unaffected, AGE concentration was lower after bicarbonate/lactate treatment (P<0.05). Effluent CA125 concentration, an indicator of mesothelial cell integrity, was higher (P<0.05) in neutral effluents. Finally, patients' inflow pain diminished (P = 0.05) when using the neutral fluid. CONCLUSIONS: The use of a neutral PD fluid in APD improved patients' inflow pain as well as biocompatibility parameters reflecting enhanced phagocytotic activity of peritoneal macrophages, reduced constitutive inflammatory stimulation (IL-6), reduced AGE accumulation in the peritoneal cavity and better preservation of the mesothelial cell integrity. From the biocompatibility point of view, a neutral fluid with low GDP content can be recommended as the primary choice for APD. 相似文献
46.
目的抗NI-35抗体(anti-NI-35antibody)作为神经再生抑制因子(NI-35)的拮抗剂对神经再生促进作用的研究是近年的热点,研究表明,抗NI-35抗体能促进体内外受损伤神经元的存活和突起生长。我们重新设计并人工合成抗NI-35重组单链抗体(anti-NI-35-scfv)的cDNA克隆构建其表达载体,在原核系统中实现初步表达。方法参照genebank中发表的抗NI-35抗体的轻链重链序列,重新设计适于在大肠杆菌中表达的目的基因片段,将该基因双链分成35个小片段合成,经退火、复性连接成目的片段后,克隆到经过BamHI和HindIII双酶切的克隆载体pUC18中,并转化大肠杆菌DH5a,抽提重组子pUC18/744进行克隆PCR、酶切鉴定及测序分析。结果测序结果证明获得的基因序列与实验设计仅差一个碱基。结论正确合成了抗NI-35重组单链抗体(anti-NI-35-single-chainantibody)为抗NI-35抗体应用于治疗弥漫性轴索损伤提供了实验基础。 相似文献
47.
《Journal of labelled compounds & radiopharmaceuticals》2006,49(12):1125-1130
Silymarin, the seed extract of milk thistle plant, Silybum marianum, has been used traditionally for the treatment of liver diseases and bile duct infection. Silybin 1 is the main bioactive components of silymarin, consisting a pair of diastereomers: Silybin A and Silybin B. In this article, we report the preparation of tritium‐labeled Silybin, which was accomplished by protection of Silybin as tritylated compound 2 and followed by oxidation of the primary alcohol to its corresponding aldehyde 3 . Subsequent reduction with NaB[3H]4 and deprotection of the trityl group provided the tritium‐labeled Silybin 4 . Copyright © 2006 John Wiley & Sons, Ltd. 相似文献
48.
采用人外周血淋巴细胞非程序DNA合成(UDS)试验和人胚肺成纤维细胞转化试验,测试了煤焦沥青烟雾提取物(ECTPF)对人体细胞的细胞毒性和遗传毒性。UDS试验结果表明,ECTPF可使淋巴细胞UDS值明显增加,并有剂量一反应关系。引起半数淋巴细胞死亡的浓度(LC50)为33.8μg/ml。细胞转化试验表明,ECTPF能诱发人胚肺成纤维细胞明显的形态学转化,且转化细胞具有部分恶性转化细胞的特性。引起半数人胚肺成纤维细胞生长抑制的浓度为41.3μg/ml。实验结果提示,ECTPF是一种具有细胞毒性和遗传毒性的物质。 相似文献
49.
50.